BBC Learning English - Learning English from the News / 50% adults overweight or obese by 2050: Global study
(Photo via Getty Images)
____________________________________________________________________________
____________________________________________________________________________
The story
More than half of all adults and a third of children, teenagers and young adults around the world are predicted to be overweight or obese by 2050. The findings come from a new study of global data, covering more than 200 countries, published in The Lancet, a well-known British medical journal.
Researchers warn that if trends continue, global rates of overweight and obese adults would increase significantly, particularly in Asia and Africa, where populations are growing.
Experts say that if governments take urgent action now, there is still time to prevent what they describe as a "profound tragedy".
News headlines
How global obesity epidemic is set to get a whole lot worse
South China Morning Post
'Unparalleled threat' of death: Over 50% of adults worldwide will be overweight by 2050
Wion
Shocking number of Brits who will be obese by 2050 revealed in damning study
The Sun
Key words and phrases
a whole lot
very much
Layla seems a whole lot happier in her new house.
unparalleled
there's nothing like it
The new genetic technology is currently unparalleled.
damning
indicates something is very negative
The critic gave the film a damning review. They said it was the worst movie of the year.
Next
If you like learning English from the news, click here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
14 minutes ago
- The Sun
Japan's moon lander ‘crashes AGAIN' in second botched mission as spaceship goes silent just moments before touchdown
A JAPANESE spacecraft attempting a touchdown on the moon has crashed into the surface, the space company said. The unmanned Resilience Moon Lander, from private Japanese astro company ispace, has been declared a failure for a second time. 2 2 Friday's flop follows the failure of the company's first attempt at a moon landing in 2023. Resilience had difficulty measuring the distance between itself and the moon, its makers said, so it careered into the surface going too fast. Following the disappointment, CFO Jumpei Nozaki said: "We're not facing any immediate financial deterioration or distress because of the event." Ispace will now have to wait years before taking another shot at a lunar landing. However, the country remains committed to the mission - and a number of private companies there are looking at moon exploration as a business opportunity. Tokyo-based ispace had hoped to join US firms Intuitive Machines and Firefly Aerospace in making successful commercial moon landings. It comes amid a global race that includes state-run lunar missions from China and India. .
The Independent
14 minutes ago
- The Independent
Statins can reduce sepsis deaths, study suggests
People who are critically ill with sepsis may be more likely to survive if they are given statins, a new study suggests. Researchers wanted to explore whether the cholesterol-busting drugs may bring additional benefits for patients. The new study examined information on sepsis patients who received statins during a stint in intensive care and compared it with patients in a similar situation who did not receive statins. Some 14.3% of 6,000 sepsis patients who were given statins died within 28 days. This is compared with 23.4% of 6,000 patients who did not receive statin therapy. The research team from China said that this equates to a 39% reduced risk of death within a month. The research, based on data from thousands of patients at a hospital in Israel between 2008 and 2019, also found that 7.4% of statin patients died while in the intensive care unit compared with 13.6% of those who did not receive statins. And during their overall hospital stay, some 11.5% of sepsis patients who were given statins died, compared with 19.1% of sepsis patients who did not take statins. However, it appeared that those who were not prescribed statins had a slightly shorter hospital stay compared with those who did receive them – an average of eight days compared with almost 10 days. 'We found that statin users exhibited decreased 28-day all-cause mortality,' the authors wrote in the journal Frontiers in Immunology. Sepsis is a life-threatening reaction to an infection that occurs when the immune system overreacts and starts to damage the body's tissues and organs. In the UK, 245,000 people are affected by sepsis every year. UK sepsis experts said that 'anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored' as they called for larger trials to confirm the findings. Statins are known as cholesterol-busting drugs because they can help lower the level of low-density lipoprotein (LDL) cholesterol in the blood. But experts said that they also have other benefits, including reducing inflammation and antibacterial effects. The research team called for larger trials to confirm their findings. 'Our large, matched cohort study found that treatment with statins was associated with a 39% lower death rate for critically ill patients with sepsis, when measured over 28 days after hospital admission,' said Dr Caifeng Li, the study's corresponding author and an associate professor at Tianjin Medical University General Hospital in China. 'These results strongly suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis.' Commenting on the study, Dr Ron Daniels, founder and chief executive of the UK Sepsis Trust, said: 'It has been known for some time that the anti-inflammatory properties of statins confer a survival benefit on those who take them if they develop sepsis. 'Whilst previous studies have failed to show a similar survival benefit in treating people with sepsis with statins, this new study supports calls for a large, multi-country, randomised control trial. 'Anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.'
Reuters
38 minutes ago
- Reuters
Japan's ex-top FX diplomat expects yen to rise near 140 by year-end
TOKYO, June 6 (Reuters) - A narrowing U.S.-Japan interest rate gap, rather than any effort by President Donald Trump to weaken the dollar, will likely lift the yen to around 135-140 against the U.S. unit by year-end, Japan's former top currency diplomat said on Friday. Markets are rife with speculation that Trump - who in the past accused Japan and China of currency manipulation - will pressure Tokyo to help weaken the dollar against the yen to give U.S. exports a trade advantage. Mitsuhiro Furusawa, a former currency diplomat who retains close ties with Japanese and overseas incumbent policymakers, said it was unclear whether the Trump administration was explicitly taking a weak-dollar policy. "It's not easy for policymakers to intentionally weaken the dollar," Furusawa said in an interview. "Having made clear that tariffs are the main tools (for negotiation), I don't think Washington needs to rely much on currencies to achieve its goals," said Furusawa, who also served as the International Monetary Fund's deputy managing director until 2021. Still, the U.S. likely wants to avoid further dollar rises from hurting exports, Furusawa said. Japan, for its part, wants to prevent a weak yen from pushing up inflation, he said. "As such, they are eye-to-eye on this front. That means the yen will likely rise gradually," said Furusawa. The diverging monetary policy direction between Japan and the U.S. will also prop up the yen with the Federal Reserve's next move seen as an interest rate cut, while the Bank of Japan (BOJ) eyes further rate hikes, Furusawa said. BOJ Governor Kazuo Ueda has said the bank will continue raising rates if economic improvements keep inflation on course to durably hit its 2% target, though he has signaled a pause until there is more clarity on the fallout from Trump's tariffs. "If Japan succeeds in reaching a broad trade agreement with the U.S. possibly at this month's G7 summit, that will reduce uncertainty," Furusawa said. Real wages will also rise and underpin consumption once food inflation dissipates, he said. "If we see such positive developments, the BOJ could hike rates again in the latter half of this year," Furusawa said, adding the yen "will likely strengthen to around 135-140 to the dollar by year-end." The yen stood around 143.90 to the dollar in Asia on Friday. The BOJ probably wants to eventually raise its short-term policy rate target - currently at 0.5% - above 1%, though there is uncertainty on whether it would succeed, said Furusawa, who is currently president of Sumitomo Mitsui Banking Corp's Institute for Global Financial Affairs. Japan is continuing trade talks with the U.S. with a focus on gaining concessions on automobile tariffs. Domestic media has reported the two sides may seek to clinch a deal in time for the G7 summit on June 15-16. Finance Minister Katsunobu Kato caused a stir last month when he said Japan could use its $1 trillion-plus holdings of U.S. Treasuries as a card in trade talks with Washington. He later said Tokyo had no plan to threaten selling U.S. Treasuries. Furusawa said it was natural for Japan, as a negotiating tactic, to say all options were on the table. But whether Japan can actually use it as a bargaining tool was questionable, partly as threatening to sell U.S. Treasuries could backfire by angering Trump and derailing trade negotiations.
